Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative IRIS chemoradiotherapy for locally advanced rectal cancer
jRCTs031180291Active, not recruiting
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tegafur and irinotecan in rectal cancer and anal cancer, sponsored by Japan Society for the Promotion of Science. Primary endpoint: Complete Response Rate. Started Mar 2017; status: active, not recruiting.
02
Drugs
tegafuririnotecan
03
Conditions
rectal canceranal cancer
Beyond the preview
Go deeper on jRCTs031180291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180291.